Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Статья

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

Kornelia KotsevaEuropean Society of Cardiology, Sophia Antipolis, FranceGuy De BackerDepartment of Public Health and Primary Care, Ghent University, BelgiumDirk De BacquerDepartment of Public Health and Primary Care, Ghent University, BelgiumLars RydénDepartment of Medicine Solna, Karolinska Institutet, Stockholm, SwedenArno W. HoesEuropean Society of Cardiology, Sophia Antipolis, FranceDiederick E. GrobbeeEuropean Society of Cardiology, Sophia Antipolis, FranceAldo P. MaggioniANMCO Research Centre, Florence, ItalyPedro Marques‐VidalDepartment of Medicine, Internal Medicine, Lausanne University Hospital, SwitzerlandCatriona JenningsEuropean Society of Cardiology, Sophia Antipolis, FranceAna AbreuHospital Santa Marta, Centro Hospitalar de Lisboa Central, Lisbon, PortugalCarlos AguíarEuropean Society of Cardiology, Sophia Antipolis, FranceJolita BadarienėCentre of Cardiology and Angiology, Vilnius University Hospital Santaros Klinikos, LithuaniaJan BruthansCentre for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer Hospital, Czech RepublicAlmudena Castro CondeCardiac Rehabilitation Unit, Cardiology Department, Hospital Universitario La Paz, Madrid, SpainRenata CífkováCentre for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer Hospital, Czech RepublicJim CrowleyDepartment of Cardiology, Galway University Hospital and Croí, the West of Ireland Cardiac and Stroke Foundation, Croí Heart and Stroke Centre, Galway, IrelandKairat DavletovSchool of Public Health, Public Health Research Centre, Kazakh National Medical University, Almaty, KazakhstanJaap W. DeckersErasmus MC, Rotterdam, The NetherlandsDelphine De SmedtDepartment of Public Health and Primary Care, Ghent University, BelgiumJohan De SutterAZ Maria Middelares Ghent, BelgiumMirza DilićEuropean Society of Cardiology, Sophia Antipolis, FranceMarina DolzhenkoSupyk National Medical Academy of Postgraduate Education, Kiev, UkraineVilnis DzērveEuropean Society of Cardiology, Sophia Antipolis, FranceAndrejs ĒrglisEuropean Society of Cardiology, Sophia Antipolis, FranceZlatko FrasEuropean Society of Cardiology, Sophia Antipolis, FranceDan GaițăEuropean Society of Cardiology, Sophia Antipolis, FranceNina GotchevaNational Heart Hospital, Dept Cardiology, Sofia, BulgariaPeter U. HeuschmannClinical Trial Centre, University Hospital Würzburg, GermanyHosam Hasan‐AliAssiut University Heart Hospital, Cardiovascular Medicine Department, EgyptPiotr JankowskiDepartment of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, PolandNebojša LalićDepartment for Metabolic Disorder, Intensive Treatment and Cell Therapy in Diabetes, Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Centre of Serbia, Belgrade, SerbiaSeppo LehtoEuropean Society of Cardiology, Sophia Antipolis, FranceDragan LovićClinic for Internal Disease Intermedic, Cardiology Department, Hypertension Centre, Nis, SerbiaS. MancasUniversitatea de Medicina si Farmacie Victor Babes, Institutul de Boli Cardiovasculare, Clinica de Recuperare Cardiovasculara, Timisoara, RomaniaLinda MellbinDepartment of Medicine Solna, Karolinska Institutet, Stockholm, SwedenDavor MiličićEuropean Society of Cardiology, Sophia Antipolis, FranceErkin М МirrakhimovEuropean Society of Cardiology, Sophia Antipolis, FranceР. Г. ОгановNational Research Centre for Preventive Medicine, Directorate, Moscow, RussiaNana PogosovaFederal State Budget Organization, National Medical Research Centre of Cardiology of the Ministry of Healthcare of the Russian Federation, Moscow, RussiaŽeljko ReinerEuropean Society of Cardiology, Sophia Antipolis, FranceStefan StörkComprehensive Heart Failure Centre, University and University Hospital Würzburg, GermanyLâle TokgözoğluDepartment of Cardiology, Hacettepe University, Ankara, TurkeyCostas TsioufisEuropean Society of Cardiology, Sophia Antipolis, FranceDuško VulićCentre for Medical Research, School of Medicine, University of Banja Luka, Republic of Srpska, Bosnia and HerzegovinaDavid WoodEuropean Society of Cardiology, Sophia Antipolis, Franceon behalf of the EUROASPIRE Investigators*
2019en
ABI

Аннотация

AIMS: The aim of this study was to determine whether the Joint European Societies guidelines on secondary cardiovascular prevention are followed in everyday practice. DESIGN: A cross-sectional ESC-EORP survey (EUROASPIRE V) at 131 centres in 81 regions in 27 countries. METHODS: Patients (<80 years old) with verified coronary artery events or interventions were interviewed and examined ≥6 months later. RESULTS: ), 59% were centrally obese (waist circumference: men ≥102 cm; women ≥88 cm) while 66% were physically active <30 min 5 times/week. Forty-two per cent had a blood pressure ≥140/90 mmHg (≥140/85 if diabetic), 71% had low-density lipoprotein cholesterol ≥1.8 mmol/L (≥70 mg/dL) and 29% reported having diabetes. Cardioprotective medication was: anti-platelets 93%, beta-blockers 81%, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers 75% and statins 80%. CONCLUSION: A large majority of coronary patients have unhealthy lifestyles in terms of smoking, diet and sedentary behaviour, which adversely impacts major cardiovascular risk factors. A majority did not achieve their blood pressure, low-density lipoprotein cholesterol and glucose targets. Cardiovascular prevention requires modern preventive cardiology programmes delivered by interdisciplinary teams of healthcare professionals addressing all aspects of lifestyle and risk factor management, in order to reduce the risk of recurrent cardiovascular events.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 3Использованных источников: 0